nodes	percent_of_prediction	percent_of_DWPC	metapath
Edetic Acid—CYP19A1—Paclitaxel—ovarian cancer	0.248	1	CbGbCtD
Edetic Acid—CYP19A1—follicular fluid—ovarian cancer	0.0943	0.292	CbGeAlD
Edetic Acid—CYP19A1—corpus luteum—ovarian cancer	0.0544	0.168	CbGeAlD
Edetic Acid—CYP19A1—ovarian follicle—ovarian cancer	0.0425	0.132	CbGeAlD
Edetic Acid—PON3—uterine cervix—ovarian cancer	0.0166	0.0515	CbGeAlD
Edetic Acid—PON3—bone marrow—ovarian cancer	0.0118	0.0364	CbGeAlD
Edetic Acid—PON3—female gonad—ovarian cancer	0.0113	0.0351	CbGeAlD
Edetic Acid—PON3—vagina—ovarian cancer	0.0113	0.0349	CbGeAlD
Edetic Acid—ADA—myometrium—ovarian cancer	0.0112	0.0347	CbGeAlD
Edetic Acid—PON3—testis—ovarian cancer	0.0101	0.0311	CbGeAlD
Edetic Acid—Nephrotic syndrome—Chlorambucil—ovarian cancer	0.00926	0.0282	CcSEcCtD
Edetic Acid—ADA—decidua—ovarian cancer	0.00832	0.0258	CbGeAlD
Edetic Acid—Pancytopenia—Altretamine—ovarian cancer	0.0075	0.0228	CcSEcCtD
Edetic Acid—ADA—female reproductive system—ovarian cancer	0.00654	0.0203	CbGeAlD
Edetic Acid—ADA—Nucleotide metabolism—NME2—ovarian cancer	0.00631	0.0628	CbGpPWpGaD
Edetic Acid—ADA—bone marrow—ovarian cancer	0.00618	0.0191	CbGeAlD
Edetic Acid—Nephropathy toxic—Vinorelbine—ovarian cancer	0.00593	0.018	CcSEcCtD
Edetic Acid—ADA—vagina—ovarian cancer	0.00592	0.0183	CbGeAlD
Edetic Acid—Bone marrow depression—Melphalan—ovarian cancer	0.00578	0.0176	CcSEcCtD
Edetic Acid—ADA—testis—ovarian cancer	0.00528	0.0163	CbGeAlD
Edetic Acid—Anaemia—Altretamine—ovarian cancer	0.00509	0.0155	CcSEcCtD
Edetic Acid—Bone marrow depression—Vinorelbine—ovarian cancer	0.00505	0.0154	CcSEcCtD
Edetic Acid—Tingling sensation—Melphalan—ovarian cancer	0.00485	0.0148	CcSEcCtD
Edetic Acid—Hyperuricaemia—Chlorambucil—ovarian cancer	0.00482	0.0147	CcSEcCtD
Edetic Acid—Blood uric acid increased—Chlorambucil—ovarian cancer	0.00455	0.0139	CcSEcCtD
Edetic Acid—ADA—Validated transcriptional targets of deltaNp63 isoforms—TP63—ovarian cancer	0.00434	0.0433	CbGpPWpGaD
Edetic Acid—Necrosis—Vinorelbine—ovarian cancer	0.00434	0.0132	CcSEcCtD
Edetic Acid—Anorexia—Altretamine—ovarian cancer	0.00428	0.013	CcSEcCtD
Edetic Acid—CYP19A1—endometrium—ovarian cancer	0.00421	0.013	CbGeAlD
Edetic Acid—Hyperuricaemia—Melphalan—ovarian cancer	0.0042	0.0128	CcSEcCtD
Edetic Acid—Numbness—Vinorelbine—ovarian cancer	0.00411	0.0125	CcSEcCtD
Edetic Acid—Nephropathy toxic—Paclitaxel—ovarian cancer	0.00399	0.0121	CcSEcCtD
Edetic Acid—Blood uric acid increased—Melphalan—ovarian cancer	0.00397	0.0121	CcSEcCtD
Edetic Acid—Sensory loss—Vinorelbine—ovarian cancer	0.00393	0.012	CcSEcCtD
Edetic Acid—Decreased appetite—Altretamine—ovarian cancer	0.0039	0.0119	CcSEcCtD
Edetic Acid—CYP19A1—gonad—ovarian cancer	0.0039	0.0121	CbGeAlD
Edetic Acid—ADA—Validated transcriptional targets of TAp63 isoforms—TP63—ovarian cancer	0.00389	0.0387	CbGpPWpGaD
Edetic Acid—CYP19A1—uterus—ovarian cancer	0.00388	0.012	CbGeAlD
Edetic Acid—Fatigue—Altretamine—ovarian cancer	0.00387	0.0118	CcSEcCtD
Edetic Acid—ADA—lymph node—ovarian cancer	0.00383	0.0118	CbGeAlD
Edetic Acid—CYP19A1—Ovarian Infertility Genes—NR5A1—ovarian cancer	0.00359	0.0358	CbGpPWpGaD
Edetic Acid—ADA—Validated transcriptional targets of deltaNp63 isoforms—YAP1—ovarian cancer	0.00357	0.0356	CbGpPWpGaD
Edetic Acid—CYP19A1—Ovarian Infertility Genes—INHA—ovarian cancer	0.0035	0.0348	CbGpPWpGaD
Edetic Acid—CYP19A1—female reproductive system—ovarian cancer	0.00349	0.0108	CbGeAlD
Edetic Acid—Lacrimation—Docetaxel—ovarian cancer	0.0033	0.01	CcSEcCtD
Edetic Acid—Asthenia—Altretamine—ovarian cancer	0.00322	0.0098	CcSEcCtD
Edetic Acid—CYP19A1—female gonad—ovarian cancer	0.00317	0.00982	CbGeAlD
Edetic Acid—CYP19A1—FSH signaling pathway—AREG—ovarian cancer	0.00296	0.0295	CbGpPWpGaD
Edetic Acid—Necrosis—Paclitaxel—ovarian cancer	0.00292	0.00888	CcSEcCtD
Edetic Acid—ADA—Validated transcriptional targets of deltaNp63 isoforms—FASN—ovarian cancer	0.00291	0.029	CbGpPWpGaD
Edetic Acid—ADA—p73 transcription factor network—TP63—ovarian cancer	0.00287	0.0286	CbGpPWpGaD
Edetic Acid—Thrombophlebitis—Vinorelbine—ovarian cancer	0.00286	0.00869	CcSEcCtD
Edetic Acid—Vomiting—Altretamine—ovarian cancer	0.00285	0.00869	CcSEcCtD
Edetic Acid—Tingling sensation—Paclitaxel—ovarian cancer	0.00285	0.00867	CcSEcCtD
Edetic Acid—CYP19A1—testis—ovarian cancer	0.00281	0.00871	CbGeAlD
Edetic Acid—Nausea—Altretamine—ovarian cancer	0.00267	0.00811	CcSEcCtD
Edetic Acid—Pancytopenia—Chlorambucil—ovarian cancer	0.00267	0.00811	CcSEcCtD
Edetic Acid—Pain—Carboplatin—ovarian cancer	0.00265	0.00807	CcSEcCtD
Edetic Acid—Sensory loss—Paclitaxel—ovarian cancer	0.00264	0.00805	CcSEcCtD
Edetic Acid—ADA—Validated transcriptional targets of TAp63 isoforms—GADD45A—ovarian cancer	0.00261	0.026	CbGpPWpGaD
Edetic Acid—Aspartate aminotransferase increased—Topotecan—ovarian cancer	0.0026	0.00792	CcSEcCtD
Edetic Acid—CYP1A2—Sulindac Metabolic Pathway—CYP1B1—ovarian cancer	0.00254	0.0253	CbGpPWpGaD
Edetic Acid—Lacrimation increased—Paclitaxel—ovarian cancer	0.00249	0.00756	CcSEcCtD
Edetic Acid—Necrosis—Docetaxel—ovarian cancer	0.00247	0.00753	CcSEcCtD
Edetic Acid—Body temperature increased—Carboplatin—ovarian cancer	0.00245	0.00746	CcSEcCtD
Edetic Acid—Pancytopenia—Topotecan—ovarian cancer	0.00237	0.00722	CcSEcCtD
Edetic Acid—ADA—p73 transcription factor network—YAP1—ovarian cancer	0.00236	0.0235	CbGpPWpGaD
Edetic Acid—Pancytopenia—Melphalan—ovarian cancer	0.00232	0.00707	CcSEcCtD
Edetic Acid—ADA—Validated transcriptional targets of deltaNp63 isoforms—BRCA2—ovarian cancer	0.00226	0.0225	CbGpPWpGaD
Edetic Acid—Lacrimation—Epirubicin—ovarian cancer	0.00223	0.00678	CcSEcCtD
Edetic Acid—Aspartate aminotransferase increased—Vinorelbine—ovarian cancer	0.00223	0.00677	CcSEcCtD
Edetic Acid—Lacrimation increased—Docetaxel—ovarian cancer	0.00211	0.00641	CcSEcCtD
Edetic Acid—Lacrimation—Doxorubicin—ovarian cancer	0.00206	0.00627	CcSEcCtD
Edetic Acid—CYP19A1—lymph node—ovarian cancer	0.00204	0.00631	CbGeAlD
Edetic Acid—Pancytopenia—Vinorelbine—ovarian cancer	0.00203	0.00618	CcSEcCtD
Edetic Acid—Hypoaesthesia—Topotecan—ovarian cancer	0.00199	0.00605	CcSEcCtD
Edetic Acid—CYP19A1—Endogenous sterols—CYP1B1—ovarian cancer	0.00198	0.0197	CbGpPWpGaD
Edetic Acid—Bone marrow depression—Epirubicin—ovarian cancer	0.00194	0.0059	CcSEcCtD
Edetic Acid—ADA—p73 transcription factor network—FASN—ovarian cancer	0.00192	0.0192	CbGpPWpGaD
Edetic Acid—Thrombophlebitis—Paclitaxel—ovarian cancer	0.00192	0.00585	CcSEcCtD
Edetic Acid—ADA—Circadian rythm related genes—TOP1—ovarian cancer	0.00191	0.019	CbGpPWpGaD
Edetic Acid—CYP19A1—Ovarian Infertility Genes—MLH1—ovarian cancer	0.00189	0.0188	CbGpPWpGaD
Edetic Acid—Tremor—Chlorambucil—ovarian cancer	0.00183	0.00557	CcSEcCtD
Edetic Acid—Nasal congestion—Paclitaxel—ovarian cancer	0.00183	0.00555	CcSEcCtD
Edetic Acid—Anaemia—Chlorambucil—ovarian cancer	0.00181	0.0055	CcSEcCtD
Edetic Acid—Bone marrow depression—Doxorubicin—ovarian cancer	0.0018	0.00546	CcSEcCtD
Edetic Acid—Chills—Topotecan—ovarian cancer	0.00179	0.00546	CcSEcCtD
Edetic Acid—CYP19A1—Ovarian Infertility Genes—PGR—ovarian cancer	0.00179	0.0178	CbGpPWpGaD
Edetic Acid—Dermatitis exfoliative—Paclitaxel—ovarian cancer	0.00176	0.00536	CcSEcCtD
Edetic Acid—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—ovarian cancer	0.00174	0.0174	CbGpPWpGaD
Edetic Acid—Hypoaesthesia—Vinorelbine—ovarian cancer	0.0017	0.00518	CcSEcCtD
Edetic Acid—Necrosis—Epirubicin—ovarian cancer	0.00167	0.00508	CcSEcCtD
Edetic Acid—ADA—Circadian rythm related genes—PPP1CC—ovarian cancer	0.00167	0.0166	CbGpPWpGaD
Edetic Acid—Thrombophlebitis—Docetaxel—ovarian cancer	0.00163	0.00495	CcSEcCtD
Edetic Acid—Glycosuria—Epirubicin—ovarian cancer	0.00162	0.00492	CcSEcCtD
Edetic Acid—Ill-defined disorder—Topotecan—ovarian cancer	0.00162	0.00491	CcSEcCtD
Edetic Acid—Anaemia—Topotecan—ovarian cancer	0.00161	0.0049	CcSEcCtD
Edetic Acid—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—ovarian cancer	0.00159	0.0158	CbGpPWpGaD
Edetic Acid—Anaemia—Melphalan—ovarian cancer	0.00158	0.00479	CcSEcCtD
Edetic Acid—Malaise—Topotecan—ovarian cancer	0.00157	0.00478	CcSEcCtD
Edetic Acid—Necrosis—Doxorubicin—ovarian cancer	0.00154	0.0047	CcSEcCtD
Edetic Acid—Anorexia—Chlorambucil—ovarian cancer	0.00152	0.00463	CcSEcCtD
Edetic Acid—Aspartate aminotransferase increased—Paclitaxel—ovarian cancer	0.0015	0.00456	CcSEcCtD
Edetic Acid—Glycosuria—Doxorubicin—ovarian cancer	0.0015	0.00455	CcSEcCtD
Edetic Acid—ADA—p73 transcription factor network—BRCA2—ovarian cancer	0.00149	0.0148	CbGpPWpGaD
Edetic Acid—Arthralgia—Topotecan—ovarian cancer	0.00148	0.00451	CcSEcCtD
Edetic Acid—Myalgia—Topotecan—ovarian cancer	0.00148	0.00451	CcSEcCtD
Edetic Acid—Discomfort—Topotecan—ovarian cancer	0.00146	0.00445	CcSEcCtD
Edetic Acid—Myalgia—Melphalan—ovarian cancer	0.00145	0.00442	CcSEcCtD
Edetic Acid—ADA—Circadian rythm related genes—HNF1B—ovarian cancer	0.00144	0.0144	CbGpPWpGaD
Edetic Acid—ADA—Nucleotide metabolism—TYMS—ovarian cancer	0.00143	0.0143	CbGpPWpGaD
Edetic Acid—CYP19A1—Ovarian Infertility Genes—CCND2—ovarian cancer	0.00143	0.0142	CbGpPWpGaD
Edetic Acid—Lacrimation increased—Epirubicin—ovarian cancer	0.00142	0.00432	CcSEcCtD
Edetic Acid—Hyperuricaemia—Epirubicin—ovarian cancer	0.00141	0.0043	CcSEcCtD
Edetic Acid—Decreased appetite—Chlorambucil—ovarian cancer	0.00139	0.00422	CcSEcCtD
Edetic Acid—Ill-defined disorder—Vinorelbine—ovarian cancer	0.00138	0.0042	CcSEcCtD
Edetic Acid—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.00138	0.00419	CcSEcCtD
Edetic Acid—Anaemia—Vinorelbine—ovarian cancer	0.00138	0.00419	CcSEcCtD
Edetic Acid—Fatigue—Chlorambucil—ovarian cancer	0.00138	0.00419	CcSEcCtD
Edetic Acid—Pancytopenia—Paclitaxel—ovarian cancer	0.00137	0.00415	CcSEcCtD
Edetic Acid—Pain—Chlorambucil—ovarian cancer	0.00136	0.00415	CcSEcCtD
Edetic Acid—Anorexia—Topotecan—ovarian cancer	0.00135	0.00412	CcSEcCtD
Edetic Acid—Malaise—Vinorelbine—ovarian cancer	0.00134	0.00409	CcSEcCtD
Edetic Acid—Blood uric acid increased—Epirubicin—ovarian cancer	0.00133	0.00406	CcSEcCtD
Edetic Acid—Anorexia—Melphalan—ovarian cancer	0.00133	0.00403	CcSEcCtD
Edetic Acid—Lacrimation increased—Doxorubicin—ovarian cancer	0.00132	0.004	CcSEcCtD
Edetic Acid—Feeling abnormal—Chlorambucil—ovarian cancer	0.00132	0.004	CcSEcCtD
Edetic Acid—Hyperuricaemia—Doxorubicin—ovarian cancer	0.00131	0.00398	CcSEcCtD
Edetic Acid—Hypotension—Melphalan—ovarian cancer	0.0013	0.00395	CcSEcCtD
Edetic Acid—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.00129	0.00394	CcSEcCtD
Edetic Acid—Paraesthesia—Topotecan—ovarian cancer	0.00128	0.00388	CcSEcCtD
Edetic Acid—Aspartate aminotransferase increased—Docetaxel—ovarian cancer	0.00127	0.00386	CcSEcCtD
Edetic Acid—Arthralgia—Vinorelbine—ovarian cancer	0.00127	0.00386	CcSEcCtD
Edetic Acid—Myalgia—Vinorelbine—ovarian cancer	0.00127	0.00386	CcSEcCtD
Edetic Acid—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.00127	0.00386	CcSEcCtD
Edetic Acid—Body temperature increased—Chlorambucil—ovarian cancer	0.00126	0.00384	CcSEcCtD
Edetic Acid—Discomfort—Vinorelbine—ovarian cancer	0.00125	0.00381	CcSEcCtD
Edetic Acid—Paraesthesia—Melphalan—ovarian cancer	0.00125	0.0038	CcSEcCtD
Edetic Acid—Decreased appetite—Topotecan—ovarian cancer	0.00123	0.00376	CcSEcCtD
Edetic Acid—Blood uric acid increased—Doxorubicin—ovarian cancer	0.00123	0.00376	CcSEcCtD
Edetic Acid—Gastrointestinal disorder—Topotecan—ovarian cancer	0.00123	0.00373	CcSEcCtD
Edetic Acid—Fatigue—Topotecan—ovarian cancer	0.00122	0.00373	CcSEcCtD
Edetic Acid—Haematuria—Paclitaxel—ovarian cancer	0.00122	0.00372	CcSEcCtD
Edetic Acid—Pain—Topotecan—ovarian cancer	0.00121	0.0037	CcSEcCtD
Edetic Acid—Decreased appetite—Melphalan—ovarian cancer	0.00121	0.00368	CcSEcCtD
Edetic Acid—Gastrointestinal disorder—Melphalan—ovarian cancer	0.0012	0.00365	CcSEcCtD
Edetic Acid—Fatigue—Melphalan—ovarian cancer	0.0012	0.00365	CcSEcCtD
Edetic Acid—Pain—Melphalan—ovarian cancer	0.00119	0.00362	CcSEcCtD
Edetic Acid—CYP1A2—Estrogen Receptor Pathway—CYP1B1—ovarian cancer	0.00118	0.0118	CbGpPWpGaD
Edetic Acid—Feeling abnormal—Topotecan—ovarian cancer	0.00117	0.00356	CcSEcCtD
Edetic Acid—Anorexia—Vinorelbine—ovarian cancer	0.00116	0.00352	CcSEcCtD
Edetic Acid—Pancytopenia—Docetaxel—ovarian cancer	0.00116	0.00352	CcSEcCtD
Edetic Acid—Asthenia—Chlorambucil—ovarian cancer	0.00114	0.00348	CcSEcCtD
Edetic Acid—Hypoaesthesia—Paclitaxel—ovarian cancer	0.00114	0.00348	CcSEcCtD
Edetic Acid—CYP19A1—Tryptophan metabolism—CYP1B1—ovarian cancer	0.00114	0.0113	CbGpPWpGaD
Edetic Acid—Hypotension—Vinorelbine—ovarian cancer	0.00114	0.00346	CcSEcCtD
Edetic Acid—Body temperature increased—Topotecan—ovarian cancer	0.00112	0.00342	CcSEcCtD
Edetic Acid—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.00111	0.00337	CcSEcCtD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—BARD1—ovarian cancer	0.0011	0.011	CbGpPWpGaD
Edetic Acid—Thrombophlebitis—Epirubicin—ovarian cancer	0.0011	0.00334	CcSEcCtD
Edetic Acid—Diarrhoea—Chlorambucil—ovarian cancer	0.00109	0.00332	CcSEcCtD
Edetic Acid—Paraesthesia—Vinorelbine—ovarian cancer	0.00109	0.00332	CcSEcCtD
Edetic Acid—Decreased appetite—Vinorelbine—ovarian cancer	0.00106	0.00321	CcSEcCtD
Edetic Acid—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.00105	0.00319	CcSEcCtD
Edetic Acid—Fatigue—Vinorelbine—ovarian cancer	0.00105	0.00319	CcSEcCtD
Edetic Acid—Pain—Vinorelbine—ovarian cancer	0.00104	0.00316	CcSEcCtD
Edetic Acid—Chills—Paclitaxel—ovarian cancer	0.00103	0.00314	CcSEcCtD
Edetic Acid—Asthenia—Topotecan—ovarian cancer	0.00102	0.0031	CcSEcCtD
Edetic Acid—Thrombophlebitis—Doxorubicin—ovarian cancer	0.00102	0.00309	CcSEcCtD
Edetic Acid—Vomiting—Chlorambucil—ovarian cancer	0.00101	0.00309	CcSEcCtD
Edetic Acid—Dermatitis exfoliative—Epirubicin—ovarian cancer	0.00101	0.00307	CcSEcCtD
Edetic Acid—Feeling abnormal—Vinorelbine—ovarian cancer	0.001	0.00305	CcSEcCtD
Edetic Acid—Asthenia—Melphalan—ovarian cancer	0.000998	0.00304	CcSEcCtD
Edetic Acid—Diarrhoea—Topotecan—ovarian cancer	0.000972	0.00296	CcSEcCtD
Edetic Acid—Hypoaesthesia—Docetaxel—ovarian cancer	0.00097	0.00295	CcSEcCtD
Edetic Acid—Body temperature increased—Vinorelbine—ovarian cancer	0.000961	0.00292	CcSEcCtD
Edetic Acid—Diarrhoea—Melphalan—ovarian cancer	0.000952	0.0029	CcSEcCtD
Edetic Acid—Nausea—Chlorambucil—ovarian cancer	0.000948	0.00288	CcSEcCtD
Edetic Acid—Tremor—Paclitaxel—ovarian cancer	0.000938	0.00286	CcSEcCtD
Edetic Acid—Dermatitis exfoliative—Doxorubicin—ovarian cancer	0.000932	0.00284	CcSEcCtD
Edetic Acid—Ill-defined disorder—Paclitaxel—ovarian cancer	0.000929	0.00283	CcSEcCtD
Edetic Acid—Anaemia—Paclitaxel—ovarian cancer	0.000926	0.00282	CcSEcCtD
Edetic Acid—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.00092	0.00917	CbGpPWpGaD
Edetic Acid—CYP1A2—Estrogen metabolism—CYP1B1—ovarian cancer	0.000912	0.00908	CbGpPWpGaD
Edetic Acid—CYP19A1—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000908	0.00905	CbGpPWpGaD
Edetic Acid—Vomiting—Topotecan—ovarian cancer	0.000903	0.00275	CcSEcCtD
Edetic Acid—Malaise—Paclitaxel—ovarian cancer	0.000903	0.00275	CcSEcCtD
Edetic Acid—Rash—Topotecan—ovarian cancer	0.000896	0.00273	CcSEcCtD
Edetic Acid—Dermatitis—Topotecan—ovarian cancer	0.000895	0.00272	CcSEcCtD
Edetic Acid—Headache—Topotecan—ovarian cancer	0.00089	0.00271	CcSEcCtD
Edetic Acid—Vomiting—Melphalan—ovarian cancer	0.000884	0.00269	CcSEcCtD
Edetic Acid—Rash—Melphalan—ovarian cancer	0.000877	0.00267	CcSEcCtD
Edetic Acid—Dermatitis—Melphalan—ovarian cancer	0.000876	0.00267	CcSEcCtD
Edetic Acid—Chills—Docetaxel—ovarian cancer	0.000875	0.00266	CcSEcCtD
Edetic Acid—Asthenia—Vinorelbine—ovarian cancer	0.000872	0.00265	CcSEcCtD
Edetic Acid—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	0.000856	0.00261	CcSEcCtD
Edetic Acid—Myalgia—Paclitaxel—ovarian cancer	0.000853	0.00259	CcSEcCtD
Edetic Acid—Arthralgia—Paclitaxel—ovarian cancer	0.000853	0.00259	CcSEcCtD
Edetic Acid—Nausea—Topotecan—ovarian cancer	0.000844	0.00257	CcSEcCtD
Edetic Acid—Discomfort—Paclitaxel—ovarian cancer	0.000842	0.00256	CcSEcCtD
Edetic Acid—Diarrhoea—Vinorelbine—ovarian cancer	0.000832	0.00253	CcSEcCtD
Edetic Acid—Nausea—Melphalan—ovarian cancer	0.000826	0.00251	CcSEcCtD
Edetic Acid—CYP1A2—Tamoxifen metabolism—CYP1B1—ovarian cancer	0.000806	0.00803	CbGpPWpGaD
Edetic Acid—CYP19A1—FSH signaling pathway—MTOR—ovarian cancer	0.000793	0.0079	CbGpPWpGaD
Edetic Acid—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.000792	0.00241	CcSEcCtD
Edetic Acid—Anaemia—Docetaxel—ovarian cancer	0.000785	0.00239	CcSEcCtD
Edetic Acid—Pancytopenia—Epirubicin—ovarian cancer	0.00078	0.00237	CcSEcCtD
Edetic Acid—Anorexia—Paclitaxel—ovarian cancer	0.000779	0.00237	CcSEcCtD
Edetic Acid—Vomiting—Vinorelbine—ovarian cancer	0.000773	0.00235	CcSEcCtD
Edetic Acid—Rash—Vinorelbine—ovarian cancer	0.000766	0.00233	CcSEcCtD
Edetic Acid—Dermatitis—Vinorelbine—ovarian cancer	0.000766	0.00233	CcSEcCtD
Edetic Acid—Hypotension—Paclitaxel—ovarian cancer	0.000764	0.00232	CcSEcCtD
Edetic Acid—Headache—Vinorelbine—ovarian cancer	0.000761	0.00232	CcSEcCtD
Edetic Acid—CYP19A1—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000746	0.00743	CbGpPWpGaD
Edetic Acid—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000745	0.00227	CcSEcCtD
Edetic Acid—CYP1A2—Estrogen Receptor Pathway—ESR1—ovarian cancer	0.000743	0.0074	CbGpPWpGaD
Edetic Acid—Paraesthesia—Paclitaxel—ovarian cancer	0.000734	0.00223	CcSEcCtD
Edetic Acid—Myalgia—Docetaxel—ovarian cancer	0.000723	0.0022	CcSEcCtD
Edetic Acid—Arthralgia—Docetaxel—ovarian cancer	0.000723	0.0022	CcSEcCtD
Edetic Acid—Pancytopenia—Doxorubicin—ovarian cancer	0.000722	0.0022	CcSEcCtD
Edetic Acid—Nausea—Vinorelbine—ovarian cancer	0.000722	0.0022	CcSEcCtD
Edetic Acid—ADA—C-MYB transcription factor network—CDKN1B—ovarian cancer	0.000712	0.00709	CbGpPWpGaD
Edetic Acid—Decreased appetite—Paclitaxel—ovarian cancer	0.000711	0.00216	CcSEcCtD
Edetic Acid—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000706	0.00215	CcSEcCtD
Edetic Acid—Fatigue—Paclitaxel—ovarian cancer	0.000705	0.00214	CcSEcCtD
Edetic Acid—Pain—Paclitaxel—ovarian cancer	0.000699	0.00213	CcSEcCtD
Edetic Acid—Haematuria—Epirubicin—ovarian cancer	0.000699	0.00213	CcSEcCtD
Edetic Acid—ADA—C-MYB transcription factor network—CCND1—ovarian cancer	0.000679	0.00676	CbGpPWpGaD
Edetic Acid—Feeling abnormal—Paclitaxel—ovarian cancer	0.000674	0.00205	CcSEcCtD
Edetic Acid—ADA—Circadian rythm related genes—TYMS—ovarian cancer	0.000671	0.00669	CbGpPWpGaD
Edetic Acid—Anorexia—Docetaxel—ovarian cancer	0.00066	0.00201	CcSEcCtD
Edetic Acid—Hypoaesthesia—Epirubicin—ovarian cancer	0.000654	0.00199	CcSEcCtD
Edetic Acid—CYP19A1—Ovarian Infertility Genes—CDKN1B—ovarian cancer	0.00065	0.00647	CbGpPWpGaD
Edetic Acid—Hypotension—Docetaxel—ovarian cancer	0.000647	0.00197	CcSEcCtD
Edetic Acid—Haematuria—Doxorubicin—ovarian cancer	0.000646	0.00197	CcSEcCtD
Edetic Acid—Body temperature increased—Paclitaxel—ovarian cancer	0.000646	0.00197	CcSEcCtD
Edetic Acid—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000631	0.00192	CcSEcCtD
Edetic Acid—CYP1A2—Melatonin metabolism and effects—CYP1B1—ovarian cancer	0.000623	0.0062	CbGpPWpGaD
Edetic Acid—Paraesthesia—Docetaxel—ovarian cancer	0.000622	0.00189	CcSEcCtD
Edetic Acid—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000606	0.00184	CcSEcCtD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—MSH2—ovarian cancer	0.000605	0.00603	CbGpPWpGaD
Edetic Acid—Decreased appetite—Docetaxel—ovarian cancer	0.000602	0.00183	CcSEcCtD
Edetic Acid—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000598	0.00182	CcSEcCtD
Edetic Acid—Fatigue—Docetaxel—ovarian cancer	0.000597	0.00182	CcSEcCtD
Edetic Acid—Pain—Docetaxel—ovarian cancer	0.000593	0.0018	CcSEcCtD
Edetic Acid—Chills—Epirubicin—ovarian cancer	0.00059	0.0018	CcSEcCtD
Edetic Acid—Asthenia—Paclitaxel—ovarian cancer	0.000586	0.00178	CcSEcCtD
Edetic Acid—CYP19A1—FSH signaling pathway—MAPK3—ovarian cancer	0.000585	0.00583	CbGpPWpGaD
Edetic Acid—ADA—C-MYB transcription factor network—NRAS—ovarian cancer	0.000585	0.00583	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—NME2—ovarian cancer	0.000573	0.00571	CbGpPWpGaD
Edetic Acid—ADA—p73 transcription factor network—MYC—ovarian cancer	0.000572	0.0057	CbGpPWpGaD
Edetic Acid—Feeling abnormal—Docetaxel—ovarian cancer	0.000571	0.00174	CcSEcCtD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—SMARCA4—ovarian cancer	0.000566	0.00563	CbGpPWpGaD
Edetic Acid—Diarrhoea—Paclitaxel—ovarian cancer	0.000559	0.0017	CcSEcCtD
Edetic Acid—CYP19A1—FSH signaling pathway—MAPK1—ovarian cancer	0.000557	0.00555	CbGpPWpGaD
Edetic Acid—Body temperature increased—Docetaxel—ovarian cancer	0.000548	0.00167	CcSEcCtD
Edetic Acid—Chills—Doxorubicin—ovarian cancer	0.000546	0.00166	CcSEcCtD
Edetic Acid—ADA—C-MYB transcription factor network—MYC—ovarian cancer	0.000545	0.00543	CbGpPWpGaD
Edetic Acid—Ill-defined disorder—Epirubicin—ovarian cancer	0.000531	0.00162	CcSEcCtD
Edetic Acid—Anaemia—Epirubicin—ovarian cancer	0.000529	0.00161	CcSEcCtD
Edetic Acid—Vomiting—Paclitaxel—ovarian cancer	0.00052	0.00158	CcSEcCtD
Edetic Acid—Malaise—Epirubicin—ovarian cancer	0.000516	0.00157	CcSEcCtD
Edetic Acid—Rash—Paclitaxel—ovarian cancer	0.000515	0.00157	CcSEcCtD
Edetic Acid—Dermatitis—Paclitaxel—ovarian cancer	0.000515	0.00157	CcSEcCtD
Edetic Acid—Headache—Paclitaxel—ovarian cancer	0.000512	0.00156	CcSEcCtD
Edetic Acid—ADA—C-MYB transcription factor network—KRAS—ovarian cancer	0.000503	0.00501	CbGpPWpGaD
Edetic Acid—Asthenia—Docetaxel—ovarian cancer	0.000497	0.00151	CcSEcCtD
Edetic Acid—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000492	0.0015	CcSEcCtD
Edetic Acid—Anaemia—Doxorubicin—ovarian cancer	0.00049	0.00149	CcSEcCtD
Edetic Acid—Arthralgia—Epirubicin—ovarian cancer	0.000488	0.00148	CcSEcCtD
Edetic Acid—Myalgia—Epirubicin—ovarian cancer	0.000488	0.00148	CcSEcCtD
Edetic Acid—Nausea—Paclitaxel—ovarian cancer	0.000486	0.00148	CcSEcCtD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—GADD45A—ovarian cancer	0.000483	0.00481	CbGpPWpGaD
Edetic Acid—Discomfort—Epirubicin—ovarian cancer	0.000482	0.00147	CcSEcCtD
Edetic Acid—Malaise—Doxorubicin—ovarian cancer	0.000478	0.00145	CcSEcCtD
Edetic Acid—Diarrhoea—Docetaxel—ovarian cancer	0.000474	0.00144	CcSEcCtD
Edetic Acid—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	0.000451	0.0045	CbGpPWpGaD
Edetic Acid—Arthralgia—Doxorubicin—ovarian cancer	0.000451	0.00137	CcSEcCtD
Edetic Acid—Myalgia—Doxorubicin—ovarian cancer	0.000451	0.00137	CcSEcCtD
Edetic Acid—Discomfort—Doxorubicin—ovarian cancer	0.000446	0.00136	CcSEcCtD
Edetic Acid—Anorexia—Epirubicin—ovarian cancer	0.000445	0.00136	CcSEcCtD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—CHEK2—ovarian cancer	0.000441	0.0044	CbGpPWpGaD
Edetic Acid—Vomiting—Docetaxel—ovarian cancer	0.000441	0.00134	CcSEcCtD
Edetic Acid—Rash—Docetaxel—ovarian cancer	0.000437	0.00133	CcSEcCtD
Edetic Acid—Hypotension—Epirubicin—ovarian cancer	0.000437	0.00133	CcSEcCtD
Edetic Acid—Dermatitis—Docetaxel—ovarian cancer	0.000436	0.00133	CcSEcCtD
Edetic Acid—Headache—Docetaxel—ovarian cancer	0.000434	0.00132	CcSEcCtD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—ovarian cancer	0.00043	0.00429	CbGpPWpGaD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—ovarian cancer	0.00043	0.00429	CbGpPWpGaD
Edetic Acid—CYP1A2—Tryptophan metabolism—CYP1B1—ovarian cancer	0.00043	0.00429	CbGpPWpGaD
Edetic Acid—ADA—C-MYB transcription factor network—HRAS—ovarian cancer	0.000428	0.00426	CbGpPWpGaD
Edetic Acid—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000426	0.0013	CcSEcCtD
Edetic Acid—Paraesthesia—Epirubicin—ovarian cancer	0.00042	0.00128	CcSEcCtD
Edetic Acid—CYP1A2—Estrogen Receptor Pathway—STAT3—ovarian cancer	0.000416	0.00414	CbGpPWpGaD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—BRCA1—ovarian cancer	0.000414	0.00412	CbGpPWpGaD
Edetic Acid—Anorexia—Doxorubicin—ovarian cancer	0.000412	0.00125	CcSEcCtD
Edetic Acid—Nausea—Docetaxel—ovarian cancer	0.000412	0.00125	CcSEcCtD
Edetic Acid—Decreased appetite—Epirubicin—ovarian cancer	0.000406	0.00124	CcSEcCtD
Edetic Acid—Hypotension—Doxorubicin—ovarian cancer	0.000404	0.00123	CcSEcCtD
Edetic Acid—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000403	0.00123	CcSEcCtD
Edetic Acid—Fatigue—Epirubicin—ovarian cancer	0.000403	0.00123	CcSEcCtD
Edetic Acid—CYP1A2—Arachidonic acid metabolism—CYP1B1—ovarian cancer	0.000403	0.00401	CbGpPWpGaD
Edetic Acid—Pain—Epirubicin—ovarian cancer	0.0004	0.00122	CcSEcCtD
Edetic Acid—CYP19A1—Biological oxidations—CYP1B1—ovarian cancer	0.000396	0.00395	CbGpPWpGaD
Edetic Acid—CYP19A1—FSH signaling pathway—AKT1—ovarian cancer	0.000395	0.00393	CbGpPWpGaD
Edetic Acid—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000394	0.0012	CcSEcCtD
Edetic Acid—CYP19A1—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000391	0.00389	CbGpPWpGaD
Edetic Acid—Paraesthesia—Doxorubicin—ovarian cancer	0.000388	0.00118	CcSEcCtD
Edetic Acid—Feeling abnormal—Epirubicin—ovarian cancer	0.000385	0.00117	CcSEcCtD
Edetic Acid—Decreased appetite—Doxorubicin—ovarian cancer	0.000376	0.00114	CcSEcCtD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—BRCA2—ovarian cancer	0.000374	0.00372	CbGpPWpGaD
Edetic Acid—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000373	0.00114	CcSEcCtD
Edetic Acid—Fatigue—Doxorubicin—ovarian cancer	0.000373	0.00113	CcSEcCtD
Edetic Acid—Pain—Doxorubicin—ovarian cancer	0.00037	0.00113	CcSEcCtD
Edetic Acid—Body temperature increased—Epirubicin—ovarian cancer	0.000369	0.00112	CcSEcCtD
Edetic Acid—ADA—Metabolism—CYTB—ovarian cancer	0.000369	0.00368	CbGpPWpGaD
Edetic Acid—Feeling abnormal—Doxorubicin—ovarian cancer	0.000356	0.00108	CcSEcCtD
Edetic Acid—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000348	0.00347	CbGpPWpGaD
Edetic Acid—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000343	0.00342	CbGpPWpGaD
Edetic Acid—Body temperature increased—Doxorubicin—ovarian cancer	0.000342	0.00104	CcSEcCtD
Edetic Acid—Asthenia—Epirubicin—ovarian cancer	0.000335	0.00102	CcSEcCtD
Edetic Acid—ADA—Circadian rythm related genes—PTEN—ovarian cancer	0.000326	0.00325	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—PPP1CC—ovarian cancer	0.000323	0.00322	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—BRIP1—ovarian cancer	0.000323	0.00322	CbGpPWpGaD
Edetic Acid—Diarrhoea—Epirubicin—ovarian cancer	0.00032	0.000973	CcSEcCtD
Edetic Acid—Asthenia—Doxorubicin—ovarian cancer	0.00031	0.000944	CcSEcCtD
Edetic Acid—CYP19A1—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000306	0.00304	CbGpPWpGaD
Edetic Acid—Vomiting—Epirubicin—ovarian cancer	0.000297	0.000904	CcSEcCtD
Edetic Acid—Diarrhoea—Doxorubicin—ovarian cancer	0.000296	0.0009	CcSEcCtD
Edetic Acid—Rash—Epirubicin—ovarian cancer	0.000295	0.000897	CcSEcCtD
Edetic Acid—Dermatitis—Epirubicin—ovarian cancer	0.000294	0.000896	CcSEcCtD
Edetic Acid—Headache—Epirubicin—ovarian cancer	0.000293	0.000891	CcSEcCtD
Edetic Acid—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000282	0.00281	CbGpPWpGaD
Edetic Acid—Nausea—Epirubicin—ovarian cancer	0.000278	0.000845	CcSEcCtD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—ESR1—ovarian cancer	0.000276	0.00275	CbGpPWpGaD
Edetic Acid—Vomiting—Doxorubicin—ovarian cancer	0.000275	0.000837	CcSEcCtD
Edetic Acid—Rash—Doxorubicin—ovarian cancer	0.000273	0.00083	CcSEcCtD
Edetic Acid—Dermatitis—Doxorubicin—ovarian cancer	0.000272	0.000829	CcSEcCtD
Edetic Acid—Headache—Doxorubicin—ovarian cancer	0.000271	0.000824	CcSEcCtD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—ovarian cancer	0.00027	0.00269	CbGpPWpGaD
Edetic Acid—Nausea—Doxorubicin—ovarian cancer	0.000257	0.000781	CcSEcCtD
Edetic Acid—CYP19A1—Metabolism—NME2—ovarian cancer	0.000242	0.00241	CbGpPWpGaD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—CDH1—ovarian cancer	0.00024	0.00239	CbGpPWpGaD
Edetic Acid—ADA—Circadian rythm related genes—TP53—ovarian cancer	0.000223	0.00222	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—YAP1—ovarian cancer	0.000217	0.00216	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000205	0.00204	CbGpPWpGaD
Edetic Acid—ADA—Circadian rythm related genes—IL6—ovarian cancer	0.000204	0.00203	CbGpPWpGaD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—MTOR—ovarian cancer	0.0002	0.00199	CbGpPWpGaD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—CASP3—ovarian cancer	0.000184	0.00183	CbGpPWpGaD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ovarian cancer	0.000184	0.00183	CbGpPWpGaD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—ovarian cancer	0.000184	0.00183	CbGpPWpGaD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ovarian cancer	0.00018	0.00179	CbGpPWpGaD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—CCND1—ovarian cancer	0.000179	0.00178	CbGpPWpGaD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—ovarian cancer	0.000177	0.00177	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—FASN—ovarian cancer	0.000177	0.00176	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—SLC5A5—ovarian cancer	0.000174	0.00173	CbGpPWpGaD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—PTEN—ovarian cancer	0.000173	0.00172	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—SLC2A1—ovarian cancer	0.000168	0.00167	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000167	0.00166	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—CYP1B1—ovarian cancer	0.000161	0.0016	CbGpPWpGaD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—ovarian cancer	0.000156	0.00156	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—CYTB—ovarian cancer	0.000156	0.00155	CbGpPWpGaD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—ovarian cancer	0.000153	0.00152	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000152	0.00152	CbGpPWpGaD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—ovarian cancer	0.000151	0.0015	CbGpPWpGaD
Edetic Acid—CYP1A2—Biological oxidations—CYP1B1—ovarian cancer	0.00015	0.00149	CbGpPWpGaD
Edetic Acid—CYP1A2—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000148	0.00147	CbGpPWpGaD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—MYC—ovarian cancer	0.000144	0.00143	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—PPP2R1A—ovarian cancer	0.000143	0.00142	CbGpPWpGaD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ovarian cancer	0.000141	0.0014	CbGpPWpGaD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—ovarian cancer	0.000141	0.0014	CbGpPWpGaD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—EGFR—ovarian cancer	0.000141	0.0014	CbGpPWpGaD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—ovarian cancer	0.000138	0.00137	CbGpPWpGaD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—ovarian cancer	0.000138	0.00137	CbGpPWpGaD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—ovarian cancer	0.000138	0.00137	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—PPP1CC—ovarian cancer	0.000136	0.00136	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—BRIP1—ovarian cancer	0.000136	0.00136	CbGpPWpGaD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—KRAS—ovarian cancer	0.000133	0.00132	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—ABCB1—ovarian cancer	0.000132	0.00132	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—TYMS—ovarian cancer	0.00013	0.0013	CbGpPWpGaD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—ovarian cancer	0.00013	0.00129	CbGpPWpGaD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—TP53—ovarian cancer	0.000118	0.00118	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000116	0.00115	CbGpPWpGaD
Edetic Acid—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	0.00011	0.0011	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—CAV1—ovarian cancer	0.000105	0.00104	CbGpPWpGaD
Edetic Acid—CYP19A1—Integrated Breast Cancer Pathway—AKT1—ovarian cancer	9.96e-05	0.000992	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	9.92e-05	0.000988	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—PIK3CG—ovarian cancer	9.54e-05	0.000951	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—NME2—ovarian cancer	9.14e-05	0.00091	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—YAP1—ovarian cancer	9.13e-05	0.000909	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	9.03e-05	0.0009	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—PIK3CD—ovarian cancer	8.39e-05	0.000836	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	7.94e-05	0.000791	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	7.75e-05	0.000772	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—FASN—ovarian cancer	7.44e-05	0.000741	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—SLC5A5—ovarian cancer	7.32e-05	0.000729	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—PIK3CB—ovarian cancer	7.31e-05	0.000728	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—SLC2A1—ovarian cancer	7.07e-05	0.000704	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	6.92e-05	0.000689	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—CYP1B1—ovarian cancer	6.78e-05	0.000675	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—PTEN—ovarian cancer	6.32e-05	0.000629	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	6.32e-05	0.000629	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—PPP2R1A—ovarian cancer	6.01e-05	0.000599	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	5.98e-05	0.000596	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—CYTB—ovarian cancer	5.89e-05	0.000586	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	5.75e-05	0.000573	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—ABCB1—ovarian cancer	5.58e-05	0.000556	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—TYMS—ovarian cancer	5.48e-05	0.000546	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—BRIP1—ovarian cancer	5.15e-05	0.000513	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—PPP1CC—ovarian cancer	5.15e-05	0.000513	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—PIK3CA—ovarian cancer	4.46e-05	0.000444	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—CAV1—ovarian cancer	4.42e-05	0.00044	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.22e-05	0.00042	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—PIK3CG—ovarian cancer	4.02e-05	0.000401	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	3.75e-05	0.000374	CbGpPWpGaD
Edetic Acid—ADA—Metabolism—AKT1—ovarian cancer	3.64e-05	0.000363	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—PIK3CD—ovarian cancer	3.54e-05	0.000352	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—YAP1—ovarian cancer	3.45e-05	0.000344	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	3.42e-05	0.00034	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—PIK3CB—ovarian cancer	3.08e-05	0.000307	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	3e-05	0.000299	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—FASN—ovarian cancer	2.81e-05	0.00028	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—SLC5A5—ovarian cancer	2.77e-05	0.000276	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—SLC2A1—ovarian cancer	2.67e-05	0.000266	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—PTEN—ovarian cancer	2.66e-05	0.000265	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.62e-05	0.000261	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—CYP1B1—ovarian cancer	2.56e-05	0.000255	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	2.27e-05	0.000226	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.26e-05	0.000225	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—ABCB1—ovarian cancer	2.11e-05	0.00021	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—TYMS—ovarian cancer	2.07e-05	0.000206	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—PIK3CA—ovarian cancer	1.88e-05	0.000187	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—CAV1—ovarian cancer	1.67e-05	0.000166	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.6e-05	0.000159	CbGpPWpGaD
Edetic Acid—CYP19A1—Metabolism—AKT1—ovarian cancer	1.54e-05	0.000153	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—PIK3CG—ovarian cancer	1.52e-05	0.000152	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—PIK3CD—ovarian cancer	1.34e-05	0.000133	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—PIK3CB—ovarian cancer	1.17e-05	0.000116	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—PTEN—ovarian cancer	1.01e-05	0.0001	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—PIK3CA—ovarian cancer	7.11e-06	7.08e-05	CbGpPWpGaD
Edetic Acid—CYP1A2—Metabolism—AKT1—ovarian cancer	5.8e-06	5.78e-05	CbGpPWpGaD
